The Journal of Organic Chemistry
Article
(s), 1040 (m), 925 (w), 810 (w), 743 (w) cm−1; 1H NMR (500 MHz,
CDCl3) δ 0.92 (t, J = 7.3 Hz, 3H), 1.27−1.45 (m, 7H), 2.17−2.25 (m,
2H), 3.00 (d, J = 6.0 Hz, 1H), 4.20−4.29 (m, 2H), 4.92 (dd, J = 0.9,
6.0 Hz, 1H), 5.31−5.38 (m, 1H), 5.70 (dt, J = 0.9, 7.3 Hz, 1H); 13C
NMR (125 MHz, CDCl3) δ 13.9, 14.0, 22.3, 27.6, 31.4, 61.9, 67.6,
126.1, 136.0, 147.2; mass spectrum m/z (relative intensity) EI 186
(0.20, M+), 168 (4.5), 157 (1), 140 (1), 113 (45), 95 (66), 83 (6), 57
(100), 55 (11).
(2), 204 (18), 189 (8), 172 (9), 158 (40), 143 (41), 133 (38), 115
(100), 91 (36), 77 (8), 55 (10), 41 (11). HRMS (EI) calcd for
[C16H22O2]+ 246.1620, found 246.1622.
(E)-Ethyl 4-(N-tert-Butoxycarbamoyl-N-methylamino)-2-oc-
tenoate (6d). Compound 6d was prepared using general procedure
A. After purification (silica gel, 10% EtOAc/90% hexanes), a clear oil
was obtained (200 mg, 75%): IR (neat) 2961 (m), 2932 (m), 2974
(w), 2966 (w) 1721 (s), 1698 (s), 1654 (w), 1463 (m), 1394 (m),
1367 (m), 1268 (m), 1152 (m), 1043 (m), 983 (w), 879 (w), 771 (w)
cm−1; 1H NMR (500 MHz, CDCl3) (minor rotamer) δ 0.82−0.90 (br,
s, 3H), 1.14−1.34 (m, 9H), 1.36−1.46 (br, s, 9H), 2.42−2.57 (br, m,
1H), (2.73) 2.81 (s, 3H), (3.07−3.17) 3.19−3.31 (m, 2H), 4.16 (q, J =
7.3 Hz, 2H), 5.77 (d, J = 15.6 Hz, 1H), 6.68−6.78 (m, 1H); 13C NMR
(125 MHz, CDCl3) (minor rotamer) δ 13.8, 14.2, 22.6, 28.3, 29.2,
31.4, 34.7 (35.2), (42.0) 42.2, (52.6) 53.1, 60.2, (79.3) 79.5, 122.4,
150.5 (150.7), 155.4 (155.8), 166.2; mass spectrum m/z (relative
intensity) EI 313 (0.03, M+), 240 (5), 194 (4), 170 (28), 144 (44),
127 (21), 99 (13), 88 (14), 57 (78), 44 (100), 41 (23); HRMS (EI)
calcd for [C17H31NO4]+ 313.2253, found 313.2258.
(Z)-Ethyl 2-Chloro-3-octenoate (4a). The Z-allylic alcohol 3 was
chlorinated by adapting the procedure from Calzada and Hooz:15 To a
round-bottom flask equipped with a magnetic stir bar and septum was
added the Z-α-hydroxy-β,γ-unsaturated ester 3 (4.0 g, 21.5 mmol) and
CCl4 (18 mL), and this mixture was stirred for 15−20 min at room
temperature. Then PPh3 (7.3 g, 28 mmol) was added in two portions
and the mixture stirred for 15 min to ensure a complete dissolution of
all the solid. A condenser was attached and the reaction mixture was
heated in an oil bath up to 75 °C (external temperature). Higher
temperatures should be avoided to prevent mixtures of cis and trans
products. The reaction was followed by TLC and normally after 1.5 h
it is complete; a bulky precipitated was present at this point. Once
cooled down to room temperature, the reaction crude was filtered over
a small layer of SiO2, eluted with 20% Et2O/80% hexanes,
concentrated in vacuo, and purified (silica gel 3% Et2O/97% hexanes).
After purification, a pale yellow oil was obtained (3.7 g, 85%): IR
(neat) 3032 (w), 2961 (m), 2933 (m), 2874 (m), 1747 (s), 1651 (w),
1466 (m), 1312 (m), 1262 (m), 1162 (s), 1027 (m), 819 (s) cm−1; 1H
NMR (500 MHz, CDCl3) δ 0.93 (t, J = 6.9 Hz, 3H), 1.29−1.45 (m,
7H), 2.12−2.22 (m, 2H), 4.25 (q, J = 6.9 Hz, 2H), 5.09 (d, J = 9.6 Hz,
1H), 5.66−5.79 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 13.8, 13.9,
22.2, 27.3, 31.2, 52.4, 62.2, 124.1, 163.9, 168.6; mass spectrum m/z
(relative intensity) EI 204 (0.10, M+), 169 (55), 141 (17), 125 (22),
95 (100), 81 (26), 67 (28), 55 (36), 41 (26); HRMS (EI) calcd for
[C10H17ClO2]+ 204.0917, found 204.0915.
(E)-Ethyl 4-Butyl-2-octenoate (6a). Compound 6a was prepared
using general procedure A. After purification (silica gel, 5% Et2O/95%
hexanes), a colorless oil was obtained (182 mg, 95%): IR (neat) 2959
(s), 2930 (s), 2860 (s), 1722 (s), 1652 (m), 1466 (m), 1369 (m),
1307 (m), 1266 (m), 1216 (m), 1176 (m), 1144 (m), 1043 (m), 988
(m), 864 (w), 730 (w) cm−1; 1H NMR (500 MHz, CDCl3) δ 0.89 (t, J
= 7.3 Hz, 3H), 1.16−1.48 (m, 15H), 2.08−2.18 (m, 1H), 4.20 (q, J =
7.3 Hz, 2H), 5.77 (d, J = 15.6 Hz, 1H), 6.75 (dd, J = 9.2, 15.6 Hz, 1H);
13C NMR (125 MHz, CDCl3) δ 14.0, 14.3, 22.7, 29.4, 34.2, 42.7, 60.1,
120.8, 154.0, 166.8; mass spectrum m/z (relative intensity) EI 226
(3.5, M+), 197 (2), 184 (25), 181 (39), 155 (18), 138 (67), 123 (28),
110 (37), 96 (200), 81 (56), 47 (69), 55 (85), 41 (10); HRMS (EI)
calcd for [C14H26O2]+ 226.1933, found 226.1932.
(E)-Ethyl 4-Methyl-2-octenoate (6b). Compound 6b was
prepared using general procedure A. After purification (silica gel, 5%
Et2O/95% hexanes), a colorless oil was obtained (137 mg, 88%): IR
(neat) 2961 (m), 2931 (m), 2874 (m), 1722 (s), 1652 (m), 1461 (m),
1266 (m), 1181 (m), 1040 (m), 985 (w), 864 (w), 725 (w) cm−1; 1H
NMR (500 MHz, CDCl3) δ 0.88 (t, J = 7.3 Hz, 3H), 1.04 (d, J = 6.9
Hz, 3H), 1.21−1.41 (m, 9H), 2.24−2.34 (m, 1H), 4.19 (q, J = 7.3 Hz,
2H), 5.77 (d, J = 15.6 Hz, 1H), 6.86 (dd, J = 7.8, 15.6 Hz, 1H); 13C
NMR (125 MHz, CDCl3) δ 13.9, 14.2, 19.4, 22.7, 29.3, 35.7, 36.5,
60.1, 119.5, 154.7, 166.9; mass spectrum m/z (relative intensity) EI
184 (4.5, M+), 169 (1.5), 155 (7), 142 (80), 139 (60), 113 (45), 96
(98), 81 (43), 69 (93), 55 (100), 41 (53).
(E)-Ethyl 4-Phenyl-2-octenoate (6c). Compound 6c was
prepared using general procedure A. After purification (silica gel, 5%
Et2O/95% hexanes), a clear oil was obtained (132 mg, 63%): IR (neat)
3063 (w), 3029 (w), 2959 (m), 2932 (s), 2860 (m), 1720 (s), 1650
(m), 1602 (w), 1494 (w), 1454 (m), 1368 (m), 1309 (m), 1267 (m),
1171 (m), 1043 (m), 985 (m), 867 (w), 761 (w), 700 (m), 560 (w)
cm−1; 1H NMR (500 MHz, CDCl3) δ 0.88 (t, J = 7.3 Hz, 3H), 1.20−
1.37 (m, 7H), 1.73−1.86 (m, 2H), 3.36−3.43 (m, 1H), 4.19 (q, J = 7.3
Hz, 2H), 5.80 (dd, J = 0.9, 15.6 Hz, 1H), 7.08 (dd, J = 7.8, 15.6 Hz,
1H), 7.17−7.36 (m, 5H); 13C NMR (125 MHz, CDCl3) δ 13.9, 14.2,
22.5, 29.6, 34.6, 48.5, 60.2, 120.6, 126.7, 127.7, 128.6, 142.4, 152.0,
166.7; mass spectrum m/z (relative intensity) EI 246 (14, M+), 217
(E)-Ethyl 4-(1,1-Dimethyl ethyl)-2-octenoate (6e). Compound
6e was prepared using general procedure A. After purification (silica
gel, 5% Et2O/95% hexanes), a clear oil was obtained (156 mg, 81%):
IR (neat) 2961 (s), 2871 (m), 1722 (s), 1651 (m), 1468 (m), 1368
(m), 1344 (m), 1266 (m), 1212 (m), 1162 (m), 1137 (m), 1040 (m),
1
992 (m), 864 (w), 730 (w) cm−1; H NMR (500 MHz, CDCl3) δ
0.82−0.92 (m, 12H), 0.98−1.08 (m, 1H), 1.16−1.36 (m, 7H), 1.51−
1.60 (m, 1H), 1.81 (dt, J = 2.3, 10.5 Hz, 1H), 4.20 (q, J = 7.3 Hz, 2H),
5.75 (d, J = 15.6 Hz, 1H), 6.78 (dd, J = 10.5, 15.6 Hz, 1H); 13C NMR
(125 MHz, CDCl3) δ 14.0, 14.2, 22.7, 27.7, 28.2, 30.4, 33.1, 53.7, 60.1,
122.4, 151.6, 166.5; mass spectrum m/z (relative intensity) EI 170
(100, M+ − tBu), 127 (79), 99 (57), 81 (18), 57 (40), 41 (24); HRMS
(EI) calcd for [C14H26O2 + H]+ 227.2011, found 227.2014.
(E)-Ethyl 4-(2-Methoxyphenyl)-2-octenoate (6g). Compound
6g was prepared using general procedure A. After purification (silica
gel, 5% Et2O/95% hexanes), a clear oil was obtained (171 mg, 73%):
IR (neat) 3032 (w), 2958 (s), 2933 (s), 2861 (m), 2839 (m), 1717
(s), 1650 (m), 1599 (m), 1493 (m), 1464 (m), 1440 (m), 1368 (m),
1
1244 (s), 1176 (s), 1032 (s), 867 (w), 754 (s), 574 (w) cm−1; H
NMR (500 MHz, CDCl3) δ 0.88 (t, J = 7.3 Hz, 3H), 1.19−1.37 (m,
7H), 1.73−1.84 (m, 2H), 3.83 (s, 3H), 3.88−3.93 (m, 1H), 4.18 (q, J
= 7.3 Hz, 2H), 5.79 (dd, J = 1.4, 15.6 Hz, 1H), 6.88 (d, J = 8.3 Hz,
1H), 6.95 (t, J = 6.9 Hz, 1H), 7.10 (dd, J = 7.8, 15.6 Hz, 1H), 7.15 (dd,
J = 1.4, 7.3 Hz, 1H), 7.22 (dt, J = 1.4, 7.8 Hz, 1H); 13C NMR (125
MHz, CDCl3) δ 13.9, 14.2, 22.6, 29.7, 33.4, 40.8, 55.4, 60.1, 110.7,
120.3, 120.7, 127.5, 127.9, 130.6, 152.0, 157.0, 167.0; mass spectrum
m/z (relative intensity) EI 276 (46, M+), 231 (25), 219 (44), 188
(22), 175 (52), 145 (100), 115 (35), 91 (29), 77 (14), 55 (9), 41 (9);
HRMS (EI) calcd for [C17H24O3]+ 276.1725, found 276.1725.
(E)-Ethyl 4-(1-Naphthyl)-2-octenoate (6h). Compound 6h was
prepared using general procedure A. After purification (silica gel, 5%
Et2O/95% hexanes), a clear oil was obtained (189 mg, 75%): IR (neat)
3049 (m), 2958 (s), 2932 (s), 2861 (m), 1936 (w), 1716 (s), 1650
(m), 1598 (w), 1510 (w), 1465 (m), 1368 (m), 1309 (m), 1269 (s),
1177 (s), 1072 (m), 986 (m), 860 (w), 798 (m), 779 (s), 733 (w)
cm−1; 1H NMR (500 MHz, CDCl3) δ 0.78 (t, J = 6.9 Hz, 3H), 1.14−
1.32 (m, 7H), 1.83−1.93 (m, 1H), 4.06 (q, J = 6.9 Hz, 2H), 4.14−4.20
(m, 1H), 5.74 (dd, J = 0.9, 15.6 Hz, 1H), 7.10−7.18 (m, 1H), 7.29−
7.46 (m, 4H), 7.67 (d, J = 7.8 Hz, 1H), 7.78 (d, J = 7.3 Hz, 1H), 7.97
(d, J = 8.3 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 13.9, 14.2, 22.7,
29.9, 34.4, 42.8, 60.3, 121.0, 123.0, 124.4, 125.4, 125.5, 126.0, 127.2,
129.0, 131.6, 134.0, 138.4, 151.7, 166.7; mass spectrum m/z (relative
intensity) EI 296 (25, M+), 251 (7), 239 (13), 223 (6), 208 (5), 179
(6), 165 (100), 153 (10), 128 (4), 115 (4), 55 (3), 41 (4) ; HRMS
(EI) calcd for [C20H24O2]+ 296.1776, found 296.1776.
(E)-Ethyl 4-[1-(2-Propenyl)]-2-octenoate (6i). Compound 6i
was prepared using general procedure A. After purification (silica gel,
5% Et2O/95% hexanes), a colorless oil was obtained (118 mg, 66%):
IR (neat) 3079 (w), 2960 (m), 2930 (m), 2860 (w), 1722 (s), 1654
(m), 1466 (w), 1369 (m), 1308 (m), 1267 (m), 1221 (m), 1176 (m),
1
1142 (m), 1043 (m), 987 (m), 914 (m), 862 (w), 726 (w) cm−1; H
11136
dx.doi.org/10.1021/jo502111c | J. Org. Chem. 2014, 79, 11125−11138